Yam JW - Search Results

1

Deleted in liver cancer 2 (DLC2) suppresses cell transformation by means of inhibition of RhoA activity.

Leung TH, Ching YP, Yam JW, Wong CM, Yau TO, Jin DY, Ng IO. Leung TH, et al. Among authors: yam jw. Proc Natl Acad Sci U S A. 2005 Oct 18;102(42):15207-12. doi: 10.1073/pnas.0504501102. Epub 2005 Oct 10. Proc Natl Acad Sci U S A. 2005. PMID: 16217026 Free PMC article.

2

Identification and characterization of EBP, a novel EEN binding protein that inhibits Ras signaling and is recruited into the nucleus by the MLL-EEN fusion protein.

Yam JW, Jin DY, So CW, Chan LC. Yam JW, et al. Blood. 2004 Feb 15;103(4):1445-53. doi: 10.1182/blood-2003-07-2452. Epub 2003 Oct 9. Blood. 2004. PMID: 14551139 Free article.

3

Rho GTPase-activating protein deleted in liver cancer suppresses cell proliferation and invasion in hepatocellular carcinoma.

Wong CM, Yam JW, Ching YP, Yau TO, Leung TH, Jin DY, Ng IO. Wong CM, et al. Among authors: yam jw. Cancer Res. 2005 Oct 1;65(19):8861-8. doi: 10.1158/0008-5472.CAN-05-1318. Cancer Res. 2005. PMID: 16204057 Free article.

4

Mitochondrial targeting of growth suppressor protein DLC2 through the START domain.

Ng DC, Chan SF, Kok KH, Yam JW, Ching YP, Ng IO, Jin DY. Ng DC, et al. Among authors: yam jw. FEBS Lett. 2006 Jan 9;580(1):191-8. doi: 10.1016/j.febslet.2005.11.073. Epub 2005 Dec 9. FEBS Lett. 2006. PMID: 16364308 Free article.

5

Interaction of deleted in liver cancer 1 with tensin2 in caveolae and implications in tumor suppression.

Yam JW, Ko FC, Chan CY, Jin DY, Ng IO. Yam JW, et al. Cancer Res. 2006 Sep 1;66(17):8367-72. doi: 10.1158/0008-5472.CAN-05-2850. Cancer Res. 2006. PMID: 16951145

6

Tensin2 variant 3 is associated with aggressive tumor behavior in human hepatocellular carcinoma.

Yam JW, Ko FC, Chan CY, Yau TO, Tung EK, Leung TH, Jin DY, Ng IO. Yam JW, et al. Hepatology. 2006 Oct;44(4):881-90. doi: 10.1002/hep.21339. Hepatology. 2006. PMID: 17006924

7

Deleted in liver cancer 1 (DLC1) negatively regulates Rho/ROCK/MLC pathway in hepatocellular carcinoma.

Wong CC, Wong CM, Ko FC, Chan LK, Ching YP, Yam JW, Ng IO. Wong CC, et al. Among authors: yam jw. PLoS One. 2008 Jul 23;3(7):e2779. doi: 10.1371/journal.pone.0002779. PLoS One. 2008. PMID: 18648664 Free PMC article.

8

Role and significance of focal adhesion proteins in hepatocellular carcinoma.

Yam JW, Tse EY, Ng IO. Yam JW, et al. J Gastroenterol Hepatol. 2009 Apr;24(4):520-30. doi: 10.1111/j.1440-1746.2009.05813.x. J Gastroenterol Hepatol. 2009. PMID: 19368632 Review.

9

Deleted in liver cancer 1 (DLC1) utilizes a novel binding site for Tensin2 PTB domain interaction and is required for tumor-suppressive function.

Chan LK, Ko FC, Ng IO, Yam JW. Chan LK, et al. Among authors: yam jw. PLoS One. 2009;4(5):e5572. doi: 10.1371/journal.pone.0005572. Epub 2009 May 15. PLoS One. 2009. PMID: 19440389 Free PMC article.

10

Deleted in liver cancer 1 isoforms are distinctly expressed in human tissues, functionally different and under differential transcriptional regulation in hepatocellular carcinoma.

Ko FC, Yeung YS, Wong CM, Chan LK, Poon RT, Ng IO, Yam JW. Ko FC, et al. Among authors: yam jw. Liver Int. 2010 Jan;30(1):139-48. doi: 10.1111/j.1478-3231.2009.02133.x. Epub 2009 Oct 27. Liver Int. 2010. PMID: 19874489

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

85 results

Search Page

Filters